Encompass Health EHC
$133.65 +$1.37 (+1.04%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $133.65 0.00%
Open$133.60
Prev close$132.28
Day range$132.55 – $134.84
Volume911.9K
Market cap$13.11B
P/E (TTM)20.9
Dividend yield0.58%
Earnings
Average move on report day±5.1%last 16 reports
Closed higher12 of 1675% of the time
Best reaction+12.6%
Worst reaction-7.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 28 Oct 2026 | After Market | ±6.8% | +7.70% | Bigger than priced |
| 2026/Q2 | 5 Aug 2026 | After Market | ±8.4% | +12.55% | Bigger than priced |
| 2026/Q1 | 30 Apr 2026 | After Market | ±7.3% | +7.48% | Bigger than priced |
| 2025/Q4 | 5 Feb 2026 | After Market | ±6.4% | +5.86% | Within range |
| 2025/Q3 | 29 Oct 2025 | After Market | ±6.9% | -7.02% | Bigger than priced |
| 2025/Q2 | 4 Aug 2025 | After Market | ±7.4% | +4.00% | Within range |
| 2025/Q1 | 24 Apr 2025 | After Market | ±9.0% | +11.79% | Bigger than priced |
| 2024/Q4 | 6 Feb 2025 | After Market | ±6.4% | +1.28% | Within range |
| 2024/Q3 | 28 Oct 2024 | After Market | ±6.6% | +7.42% | Bigger than priced |
| 2024/Q2 | 5 Aug 2024 | After Market | ±5.9% | -5.56% | Within range |
| 2024/Q1 | 24 Apr 2024 | After Market | ±7.9% | -0.08% | Within range |
| 2023/Q4 | 7 Feb 2024 | After Market | ±5.7% | +0.95% | Within range |
| 2023/Q3 | 26 Oct 2023 | After Market | ±7.2% | -0.62% | Within range |
| 2023/Q2 | 1 Aug 2023 | After Market | ±5.4% | +5.09% | Within range |
| 2023/Q1 | 27 Apr 2023 | None | ±6.6% | +1.12% | Within range |
| 2022/Q4 | 7 Feb 2023 | After Market | ±5.5% | +2.70% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.61B+8.9% YoY
Operating profit$288.00M+18.2% YoY
Net profit$203.60M+16.6% YoY
Diluted EPS$1.50+21.0% YoY
Free cash flow$127.50M+52.3% YoY
Operating cash flow$362.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin95.9%
Operating margin18.3%
Net margin10.1%
Return on equity25.4%
Return on assets8.9%
Return on invested capital14.1%
Current ratio1.09
Liabilities / assets52.9%
Cash & investments$76.20M
Total debt$2.78B
Net cash (debt)-$2.70B
Free cash flow / sales7.2%
No comments yet — be the first to weigh in on EHC.
Sign in to join the discussion.